211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
for
Acute Lymphoblastic Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT03128034
Phase1, Phase2, Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: New York NY, Richmond VA, Tampa FL, Atlanta GA,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT06137118
Phase1, Phase2, Recruiting
Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
for
KSHV Inflammatory Cytokine Syndrome (KICS),
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT06052618
Phase2, Recruiting
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
for
Sezary Syndrome, Mycosis Fungoides
Location: Stanford CA
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT04256018
Phase2, Recruiting
Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0+
Code: NCT05108519
Recruiting
Interested in new lymphoma trials?
Get alerts for new trials in your area by subscribing now
SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)
for
Gastrointestinal Cancer, Hematologic Cancer, Thoracic Cancer
Location: Boston MA, Brighton MA
Sponsor: Nadine Jackson, MD, MPH
Sex: All
Age: 18+
Code: NCT05375643
Recruiting
CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
for
Acute Lymphoblastic Leukemia,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 21
Code: NCT06777979
Phase1, Recruiting
UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1